View graph of relations


    Garry Laverty graduated with a First Class Honours Masters degree (MPHARM) from the School of Pharmacy at Queen's University Belfast in 2005.  After successful completion of his pre-registration training Garry commenced a PhD in Pharmaceutics related to the activity of peptides against the biofilm forms of medical device related pathogens. 

    In 2010 Garry began employment within the biotechnology industry. He was responsible for the creation and development of innovative veterinary products working closely with the School of Pharmacy at Queen’s University Belfast. Garry has also undertaken a Postgraduate Diploma in Management Practice at University College Dublin. His work with small to medium enterprise allows him to fulfil his role as an Intertrade Ireland FUSION Graduate Ambassador.

    Garry maintains his close links to Community Pharmacy and the Pharmaceutical Industry.  He is a Member of the Pharmaceutical Society (MPSNI) and an external examiner at Trinity College Dublin.

    In October 2012, Garry was appointed to the position of Lecturer in Pharmaceutical Science and Practice at the School of Pharmacy, Queen's University Belfast.

    Research Interests

    Dr. Laverty's Biofunctional Nanomaterials group research the design and development of self-assembling nanostructures/platforms for biomedical applications based on the building blocks of life (carbohydrates, lipids, proteins, and nucleic acids). These  structures have the ability to form nanofibrous hydrogels or nanotubular structures with high surface to volume ratios in the presence of specific physiological stimuli (e.g. pH, temperature, enzymes). They have huge potential within the fields of drug delivery and biomaterials with the group's focus primarily on the development of antimicrobial/anticancer technologies, sustained release drug delivery systems and molecules with the ability to transverse the biological barriers (e.g. blood-brain barrier, outer membrane of Gram-negative bacteria).

    His work is funded by the Wellcome Trust, the Royal Society, the Society for Applied Microbiology, the Biochemical Society and Intertrade Ireland.

    Dr Laverty's most recent work relates to the development of self-assembling peptide-based hydrogel materials for use against infection. Harnessing a "bottom-up" approach, variation of the primary amino acid sequence allows structures to spontaneously assemble into ordered nanostructures upon exposure to varying environmental factors/stimuli. The peptide backbone provides a unique primer for tailoring biocompatibility, biodegradability and functionality.

    His work on the use of ultrashort self-assembling peptide gels against resistant biofilm forms of hospital superbugs attracted interest from national and international media outlets including BBC, RTE and UTV television and radio, The Belfast Telegraph, The Irish Times, WTOP radio Washington D.C and abc News.


    Dr. Laverty is a member of the Society for Applied Microbiology (SfAM), the European Peptide Society, the Royal Society of Chemistry, the American Chemical Society and is a member of the EPSRC Peer Review College.


    Master's of Pharmacy Degree (MPHARM)

    Level 1: Practising as a Pharmacist (PMY 1017)

    Level 2: Pharmaceutical Technology (PMY 2006)

    Pharmaceutical Statistics

    Co-ordinator of Industrial Stakeholder's Workshops

    Level 2: Medicinal Substances (PMY 2126) 

    Level 4: Business, Government & Industry (PMY 4002): Co-ordinator of Industrial component and Entrepreneurial Workshops

    Level 4: Project Module (PMY 4005)

    Facilitator within Pharmacists in Schools Programme


    BSc Pharmaceutical Sciences and Biotechnology:

    Level 1: Mathematical and Statistical Skills (PMY1020)

    Level 2: Industrial Pharmaceutics (PMY2020)

    Module lead on Pharmaceutical Formulation practical

    Medicinal Substances (PMY2024)

    Level 3: Module Coordinator: PMY3021: Quality Assurance and Regulatory Aspects of Pharmaceutical Manufacture

    Pharmaceutical Science Research Project (PMY3022)


    Visting Lecturer China Queen's College (Shenyang, China)


    MSc Pharmaceutical Analysis:

    Quality Assurance/Control in the Pharmaceutical Industry (PMY8104)

    Quality of Analytical Methods (PMY8105)

    Research Project Supervisor (CHM8029)

    Willingness to take PhD students


    PhD projects

    Open to PhD applications in the field of peptide-based materials (hydrogels and nanotubes), sustained and targeted drug delivery, biomaterials, antimicrobial drug design.

    View all

    Frequent Journals

    • Future microbiology

      ISSNs: 1746-0913

      Additional searchable ISSN (Electronic): 1746-0921

      Future Medicine Ltd.

      Scopus rating (2018): CiteScore 2.55 SJR 1.065 SNIP 0.805


    • Chemical Biology & Drug Design

      ISSNs: 1747-0277

      Additional searchable ISSN (Electronic): 1747-0285


      Scopus rating (2018): CiteScore 2.32 SJR 0.597 SNIP 0.708


    • American Journal of Pharmaceutical Education

      ISSNs: 0002-9459

      Additional searchable ISSN (Electronic): 1553-6467

      American Association of Colleges of Pharmacy

      Scopus rating (2018): CiteScore 1.22 SJR 0.63 SNIP 1.099


    • Journal of Pharmacy and Pharmacology

      ISSNs: 0022-3573

      Additional searchable ISSN (Electronic): 2042-7158

      Pharmaceutical Press

      Scopus rating (2018): CiteScore 2.32 SJR 0.568 SNIP 0.772


    • Journal of peptide science

      ISSNs: 1075-2617

      Additional searchable ISSN (Electronic): 1099-1387

      John Wiley and Sons Ltd

      Scopus rating (2018): CiteScore 1.91 SJR 0.662 SNIP 0.564


    View all »

    View all

    View all

    Contribution to conference papers, events and activities

    ID: 1846499